 Postischemic therapy focal ischemic brain injury rats -Emopamil calcium channel blocker phenylalkylamine class potent serotonin antagonistic properties high blood-brain barrier penetrability Previous studies cerebroprotective effect animal models focal global ischemia present study postischemic window therapeutic efficacy agent Sprague-Dawley rats proximal middle cerebral artery occlusion initial period halothane-induced hypotension Hg -Emopamil mg/kg minutes cerebral artery occlusion hour hours hours occlusion groups second similar dose hours days Brains perfusion-fixed third day Planimetric analysis hemotoxylin eosin-stained coronal brain sections cortical infarct mean SD untreated rats Cortical infarct volume therapy hour postischemia treatment hours postichemia mean cortical infarct volume difference statistical significance Infarct volume rats treatment hours postischemia indistinguishable controls Striatal infarct volume similar groups results postischemic therapeutic window cerebroprotection hours middle cerebral artery occlusion